185 related articles for article (PubMed ID: 8175651)
21. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules.
Gitay-Goren H; Soker S; Vlodavsky I; Neufeld G
J Biol Chem; 1992 Mar; 267(9):6093-8. PubMed ID: 1556117
[TBL] [Abstract][Full Text] [Related]
22. Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain.
Mamluk R; Gechtman Z; Kutcher ME; Gasiunas N; Gallagher J; Klagsbrun M
J Biol Chem; 2002 Jul; 277(27):24818-25. PubMed ID: 11986311
[TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor is inactivated by binding to alpha 2-macroglobulin and the binding is inhibited by heparin.
Soker S; Svahn CM; Neufeld G
J Biol Chem; 1993 Apr; 268(11):7685-91. PubMed ID: 7681826
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases.
Maruyama K; Mori Y; Murasawa S; Masaki H; Takahashi N; Tsutusmi Y; Moriguchi Y; Shibazaki Y; Tanaka Y; Shibuya M; Inada M; Matsubara H; Iwasaka T
J Mol Cell Cardiol; 1999 Mar; 31(3):607-17. PubMed ID: 10198191
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the VEGF binding site on the Flt-1 receptor.
Herley MT; Yu Y; Whitney RG; Sato JD
Biochem Biophys Res Commun; 1999 Sep; 262(3):731-8. PubMed ID: 10471394
[TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial growth factor (VEGF) receptor II-derived peptides inhibit VEGF.
Piossek C; Schneider-Mergener J; Schirner M; Vakalopoulou E; Germeroth L; Thierauch KH
J Biol Chem; 1999 Feb; 274(9):5612-9. PubMed ID: 10026178
[TBL] [Abstract][Full Text] [Related]
27. Cloning and functional analysis of the promoter for KDR/flk-1, a receptor for vascular endothelial growth factor.
Patterson C; Perrella MA; Hsieh CM; Yoshizumi M; Lee ME; Haber E
J Biol Chem; 1995 Sep; 270(39):23111-8. PubMed ID: 7559454
[TBL] [Abstract][Full Text] [Related]
28. Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro.
Shen BQ; Lee DY; Gerber HP; Keyt BA; Ferrara N; Zioncheck TF
J Biol Chem; 1998 Nov; 273(45):29979-85. PubMed ID: 9792718
[TBL] [Abstract][Full Text] [Related]
29. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.
Seetharam L; Gotoh N; Maru Y; Neufeld G; Yamaguchi S; Shibuya M
Oncogene; 1995 Jan; 10(1):135-47. PubMed ID: 7824266
[TBL] [Abstract][Full Text] [Related]
30. A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain.
Ogawa S; Oku A; Sawano A; Yamaguchi S; Yazaki Y; Shibuya M
J Biol Chem; 1998 Nov; 273(47):31273-82. PubMed ID: 9813035
[TBL] [Abstract][Full Text] [Related]
31. VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding.
Soker S; Miao HQ; Nomi M; Takashima S; Klagsbrun M
J Cell Biochem; 2002; 85(2):357-68. PubMed ID: 11948691
[TBL] [Abstract][Full Text] [Related]
32. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
Aiello LP; Pierce EA; Foley ED; Takagi H; Chen H; Riddle L; Ferrara N; King GL; Smith LE
Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10457-61. PubMed ID: 7479819
[TBL] [Abstract][Full Text] [Related]
33. Kinase insert domain receptor (KDR) extracellular immunoglobulin-like domains 4-7 contain structural features that block receptor dimerization and vascular endothelial growth factor-induced signaling.
Tao Q; Backer MV; Backer JM; Terman BI
J Biol Chem; 2001 Jun; 276(24):21916-23. PubMed ID: 11399777
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells.
Takagi H; King GL; Ferrara N; Aiello LP
Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1311-21. PubMed ID: 8641834
[TBL] [Abstract][Full Text] [Related]
35. Differential expression of vascular endothelial growth factor and its receptor mRNAs in the mouse uterus around the time of implantation.
Chakraborty I; Das SK; Dey SK
J Endocrinol; 1995 Nov; 147(2):339-52. PubMed ID: 7490564
[TBL] [Abstract][Full Text] [Related]
36. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis.
Keyt BA; Nguyen HV; Berleau LT; Duarte CM; Park J; Chen H; Ferrara N
J Biol Chem; 1996 Mar; 271(10):5638-46. PubMed ID: 8621427
[TBL] [Abstract][Full Text] [Related]
37. Co-expression of vascular endothelial growth factor (VEGF) and its receptors (flk-1 and flt-1) in hormone-induced mammary cancer in the Noble rat.
Xie B; Tam NN; Tsao SW; Wong YC
Br J Cancer; 1999 Dec; 81(8):1335-43. PubMed ID: 10604730
[TBL] [Abstract][Full Text] [Related]
38. 2'-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain.
Ruckman J; Green LS; Beeson J; Waugh S; Gillette WL; Henninger DD; Claesson-Welsh L; Janjić N
J Biol Chem; 1998 Aug; 273(32):20556-67. PubMed ID: 9685413
[TBL] [Abstract][Full Text] [Related]
39. Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.
Héroult M; Bernard-Pierrot I; Delbé J; Hamma-Kourbali Y; Katsoris P; Barritault D; Papadimitriou E; Plouet J; Courty J
Oncogene; 2004 Mar; 23(9):1745-53. PubMed ID: 15001987
[TBL] [Abstract][Full Text] [Related]
40. HCPTPA, a protein tyrosine phosphatase that regulates vascular endothelial growth factor receptor-mediated signal transduction and biological activity.
Huang L; Sankar S; Lin C; Kontos CD; Schroff AD; Cha EH; Feng SM; Li SF; Yu Z; Van Etten RL; Blanar MA; Peters KG
J Biol Chem; 1999 Dec; 274(53):38183-8. PubMed ID: 10608891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
